tissue eng. cartilage final presentation (1)

Upload: gregory-lynn

Post on 02-Jun-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    1/32

    Tissue Engineeringof

    CartilageEvan WitmerGregory Lynn

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    2/32

    Cartilage Basics

    Ailments, Traditional Treatments, &Tissue Engineering

    Six Current Publications Objective & Justification Methods & Materials Results

    Summary

    Acknowledgements

    Overview

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    3/32

    What is Cartilage?

    Gel-like connective tissue made

    up of chondrocytes, collagen,proteoglycans, and other ECM

    proteins

    70-80%water

    Avascular

    no nutrients, no regeneration

    3 types:

    Hyaline (low-friction)

    Elastic (epiglottis)

    Fibrocartilage (shock absorbing)

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    4/32

    Ailments & Traditional Treatme

    Causes: Trauma, chronic wea

    developmental disorders, im

    Little-to-no natural regen Autografts (self) / Allogr

    transplantation of do Debridement (smoothing Marrow stimulation

    Problems: site morbidity, lim

    availability, immune responsPrimary Source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146065/

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    5/32

    Advent ofTissue Engineerin

    Creates an embryonic-like environment that stimulates grow Custom-made scaffolds for strength, structure, and function Resulting structure is true self-regenerated tissue Single surgery required

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    6/32

    Objective: To better assess the applicability of the electrospinnintechnology for scaffold fabrication, through electrospinning six co(-hydroxy esters) and testing their characteristics

    Electrospinning high surface area to volume ratio similar structural morphology to the fibrillar ECM

    Poly(-hydroxy esters) biodegradable & FDA approved

    IF: 5.68 - (200

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    7/32

    Methods & Materials

    6 Poly(-hydroxy esters)spun into fibrous scaffolds

    A.) PGAB.) PLGA5050

    C.) PDLLA

    D.)PLGA8515

    E.) PLLA

    F.) PCL

    Analysis Coat in gold & SEM Apply load

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    8/32

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    9/32

    Results

    Cell-Matrix Interaction (After 7 days) Remained on surface of PGA, PDLLA, PLGA5050, and PL

    Chondrocytes integrated into PLLA & PCL Cellular proliferation

    Chondrocytes Mesenchymal Stem Ce

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    10/32

    (201Objective: To describe the developmental physicochemical pro

    silk fibroin scaffolds derived from high-concentrationaqueousolutions.

    Silk fibroin in vivo degrades easily tailored & processed

    More than 10% aqueous silk fibroin solution

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    11/32

    Methods & Materials

    Silk fibroin scaffolds with

    different initialconcentrations(in wt.%)

    A.) 8%

    C.) 10%

    E.) 12%

    G.) 16%,

    Combined methodology Salt-leaching & freeze-

    drying Create different

    structures

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    12/32

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    13/32

    Results

    All above 90% interconnectivityand79% porosity

    ~15% of pores larger than 300m Water up-take (30 days immersion)

    Original weights No significant differencein

    morphology Mechanical Properties

    Silk-16& Silk-12values suitablefor meniscus and cartilageengineering

    Compressive

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    14/32

    European Cel(2008)

    Objective: To evaluate in vivo cartilaginous tissue formation by cseeded fibrin/PLGA hybrid scaffolds.

    Joint replacement PGLA & fibrin scaffolds

    in vitro promoted cartilage constructs

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    15/32

    Methods & Materials

    fibrin/PLGA hybrid (A) PLGA scaffolds soaked in

    chondrocyte-fibrin solution

    Control: Chondrocytes seededintojust PLGA (B)

    Implanted into dorsum of nudemice 4 weeks

    A

    B

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    16/32

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    17/32

    Results

    Fibrin/PLGA hybrid superior Higher cell viability and

    proliferation Superior cell distribution, cell-

    matrix organization, overallECM production

    Fibrin/PLGA

    PLGA

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    18/32

    Biomac(2005

    Objective: To combine the benefits of a photocrosslinkable netwthe desirable material HA for cartilage tissue engineering.

    Hyaluronic Acid (HA) forms aggrecans (proteoglycan CSPCP) &

    wound healing Hydrogels photoencapsulate chondrocytes

    Easier to fill tight spaces and irregularly shaped defects

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    19/32

    Materials & Methods

    Materials:

    HA and methacrylic anhydrideform MeHA Polyethylene glycol

    dimethacrylate (PEGDM) Swine chondrocytes Nude mice

    Methods: Fabrication of MeHA & PEGDM Encapsulation by polymerizing with UV light Culture in nude mice 4, 6, and 8 week dissection

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    20/32

    Results

    Mechanical properties linear slope at low strains

    (

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    21/32

    Results Cell viability

    Decrease in viability with increase inmonomer concentration

    Effect of molecular weight wasnegligible

    1 day (black) 1 w

    immediate (black), 4 weeks (gray), 8 weeks (white)

    Neocartilage formation After 4 weeks, all co

    became opaque. StaGAG formation

    As effective as the Pbased hydrogel

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    22/32

    (200IF: 8.

    Objective: Study aims to form non-toxic composite and study meproperties and degradation of chitosan-HAin vitro.

    New Material: water-soluble chitosan and oxidized hyaluroni

    without toxic cross-linking Crosslinking action with amino functions

    No photopolymerization to prevent prolonged irradiation, nophotosensitizer (toxic)

    h d i l

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    23/32

    Methods & Materials

    Materials: Chitosan

    HA sodium Succinic anhydride Bovine chondrocytes

    Methods Succinyl-CS and Aldehyde-HA

    synthesized and lyophilized

    Hydrogels formed by mixing ratios of1:9, 3:7, 7:3, 9:1

    Schiffs base crosslinking reaction Encapsulation:

    Mix cells with S-CS, Add A-HA to form gel

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    24/32

    Results

    Cell adhesion 5:5 & 7:3 signif

    greater than 3

    Degradation rate strong correlation to ratio of S-

    CS to A-HA more S-CS = slower weight loss

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    25/32

    Results

    Cell proliferation and viability successful encapsulation

    in a normal sphericalmorphology

    promoted cell survival

    Successful crospossible with mreagents

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    26/32

    (2004)IF: 8.31

    Objective: To study the response of bovine chondrocytes on natichemically modified BC (Phosphorylation & Sulfation)

    Bacterial cellulose (BC) has unusual material properties & deg

    high water retention, fiber network, high wet tensile stre cost-effective mass producible BC mold

    Lack of literature describing native mechanical properties forconstructs

    M th d & M t i l

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    27/32

    Methods & Materials Materials

    G. xylinus H

    3PO

    4

    NH2SO3H Bovine chondrocytes

    Methods G. xylinus grown & BCpurified Phosphorylation

    BC-P1 (30 min), BC-P2 (2 hr)

    Sulfation BC-S

    Cultured human arterial cartilage for 8days collagen type II, plant-derived

    cellulose, calcium alginate, and

    tissue culture plastic

    l

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    28/32

    Results

    Modifications changedsurface morphology to

    adhere more strongly

    Strong immune responseto native BC

    Modified BC showshigher growth at similarimmune response toalginate & tissue cultureplastic

    R lt

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    29/32

    Results

    Presence of cellingrowthpromisingfor scaffoldmaterialengineering

    BC does notprematurelydifferentiate cellsto form fibroblasts

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    30/32

    Summary

    Scaffold Materials:

    Synthetics PGA, PLLA, PDLLA,

    PLGA5050, PLGA8515, PCL Natural

    Silk, Bacterial Cellulose, HA,Chitosan

    Huge variety of materials

    Techniques:

    Electrospinning,Lyophilization,Injectable HydrogPhotopolymeriza

    Cross-linkinggenerally determdegradation rate

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    31/32

    Future of Cartilage TE

    Hydrogels mimicking ECM-like matrices Self-assembling nanoscaffolds Thermosensitive injectable materials Biomimetic novel materials (coral, silk, etc.)

  • 8/10/2019 Tissue Eng. Cartilage Final Presentation (1)

    32/32

    Acknowledgements

    Dr. Abidian

    Evan Witmer

    Greg Lynn